GL1X · GenesisL1 explorer

MolNFT v1 · #10105 · protein

Type 1 insulin-like growth factor receptor (domains 1-3)

1IGR · Insulin-like growth factor receptor 1: “Type 1 insulin-like growth factor receptor (domains 1-3)”. X-ray diffraction, 5 ligands (NAG, FUC, BMA), 5 pockets (best druggability 0.51). MolNFT v1 #10105 on GenesisL1: 3D structure…

PDB
1IGR
Type
protein
Length
471 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Insulin-like growth factor receptor 1
EC
2.7.10.1
UniProt
P08069
Ligands
NAG, FUC, BMA, MAN, SO4
Pockets
5 · best druggability 0.51

Structure

x-ray diffraction · 1 distinct chain · 11% helix, 27% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AInsulin-like growth factor receptor 1 (EC 2.7.10.1)protein47111% helix, 27% strandP08069

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 6 copies · chains A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A
  • BMA · beta-D-mannopyranose · sugar
  • MAN · alpha-D-mannopyranose · sugar
  • SO4 · Sulfate ion · ion · 8 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11460.510.7921SO4
2720.380.7818empty
3870.340.7415empty
4540.290.7514empty
5540.260.7319empty

Modifications

Observed in the structure: 15 disulfide, 4 glycan (disulfide, N-glycosylation).

Compared structures

  • 1IGR · Type 1 Insulin-like growth factor receptor (DOMAINS 1-3) · the same entry in another collection · chain A against A, TM-score 1.00
  • P08069 · AlphaFold monomer V2.0 prediction for insulin-like growth factor 1 receptor (P08069) · a predicted model of the same protein · chain A against A, TM-score 0.88

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.